Smith & Nephew
Tracked across 6 events · 41 articles · First seen Jun 08, 2026 · Last active Aug 18, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Tech
Impact: Smith+Nephew announced the completion of the first clinical cases using its new Cori Surgical System, marking a significant advancement in its product portfolio and potentially increasing its market share in orthopaedic surgery.
Jun 08, 2026 · 7 articles
Business
Impact: Smith+Nephew supported the consensus and stands to benefit from increased adoption of its PICO7 system in Germany, potentially improving revenue in its Advanced Wound Management segment.
Jul 09, 2026 · 6 articles
Business
Impact: Smith+Nephew launched the LYNX COBLATION Laryngeal Wand, expanding its ENT product line. The launch is a positive but incremental development for the company.
Jul 15, 2026 · 6 articles
Regulatory
Impact: Smith+Nephew received FDA De Novo classification for its TESSA system, reinforcing its leadership in digital sports medicine and potentially driving future revenue.
Jul 29, 2026 · 7 articles
Tech
Smith+Nephew, a global medical technology company, and Imperial College London have launched a five-year partnership to establish a new university technology centre for robotic surgery for musculoskeletal conditions. The centre, located within Imperial's Hamlyn Centre,…
Impact: Smith+Nephew is the primary corporate partner, investing in the new centre to accelerate innovation in robotic surgery. This partnership could enhance its product pipeline and competitive position in the medical technology sector.
Aug 18, 2026 · 7 articles
Business
Impact: Key player; wound care and orthopedic segments benefit from market growth.
Jul 21, 2026 · 8 articles
ERGEN INTELLIGENCE
Track Smith & Nephew live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard